World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   29 records for 23 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingACTRN12615000031561
The Fluid Translation of Research into Practice Study - Discrete Choice Experiment (Survey) of Intensive Care clinicians preferences of resuscitation fluid.
19/01/2015
RecruitingNCT01942174
VACcination In Methotrexate Treated Rheumatoid Arthritis Patients
10/09/2013
Not recruitingNCT01899365
An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department
04/07/2013
RecruitingNCT01864850
Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
21/05/2013
Not recruitingNCT01826344
The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study
03/04/2013
Not recruitingNCT01718379
Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
23/10/2012
Not recruitingNCT01677052
THERMOCOOL® SMARTTOUCH™ Registry
29/08/2012
AuthorisedEUCTR2012-000669-19-ES
A study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2012-000669-19-GRA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).09/08/2012
AuthorisedEUCTR2012-000669-19-GBA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).16/08/2012
AuthorisedEUCTR2012-000669-19-NLA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).10/07/2012
AuthorisedEUCTR2012-000669-19-FIA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).09/07/2012
AuthorisedEUCTR2012-000669-19-FRA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).17/09/2012
AuthorisedEUCTR2012-000669-19-IEA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).06/09/2012
AuthorisedEUCTR2012-000669-19-PTA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).26/11/2012
AuthorisedEUCTR2012-000669-19-ITA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).31/08/2012
AuthorisedEUCTR2012-000669-19-BEA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).26/09/2012
AuthorisedEUCTR2012-000669-19-BGA study comparing efficacy of subcutaneous (SC) rituximab and intravenous (IV) rituximab both in combination with CHOP (R-CHOP) in previously untreated patients with CD20 positive diffuse large B-cell lymphoma (DLBCL).29/10/2012
RecruitingNCT01649856A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma23/07/2012
12/06/2012
Not recruitingNCT01557348
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
13/03/2012
Not recruitingNCT01543737
Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee
20/02/2012
    
1 2 3
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history